American Medical Association (AMA)

The American Medical Association (AMA) is the largest professional association and lobbying group of physicians and medical students. The AMA mission is to promote the art and science of medicine and the betterment of public health. The association represents physicians with a unified voice in courts and legislative bodies across the nation, removing obstacles that interfere with patient care, leading efforts to prevent chronic disease and confront public health crises, and driving the future of medicine to tackle the biggest challenges in healthcare.

Heart failure patients on quadruple medical therapy still face considerable risks
Most patients hospitalized for HFrEF are still not being prescribed quadruple medical therapy at discharge. Even those who are, researchers noted, still face a high risk of dying or returning to the hospital for heart failure-related symptoms.
Low-volume operators linked to worse outcomes after TAVR, M-TEER
Researchers tracked data from more than 400,00 patients, sharing their findings in JAMA Cardiology.
Radiology dominates FDA-cleared AI, but reimbursement lags far behind
As of January 2026, there will only be two CPT category 1 payment codes for newer AI, despite there being hundreds of FDA-cleared medical imaging algorithms.
Court dismisses nurse practitioners’ lawsuit challenging definition of ‘doctor’
The court's ruling is backed by the American Medical Association, which submitted an amicus brief arguing that "scope creep" threatens patient safety.
New-onset AFib is common after CABG—but typically not persistent or symptomatic
The study's authors questioned if these patients should even be given oral anticoagulation as currently recommended.

Heart failure patients on quadruple medical therapy still face considerable risks

Most patients hospitalized for HFrEF are still not being prescribed quadruple medical therapy at discharge. Even those who are, researchers noted, still face a high risk of dying or returning to the hospital for heart failure-related symptoms.

Low-volume operators linked to worse outcomes after TAVR, M-TEER

Researchers tracked data from more than 400,00 patients, sharing their findings in JAMA Cardiology.

Eric Rubin, MD, vice president of clinical operations at Virtua Health, and the American College of Radiology's CPT advisor to the American Medical Association (AMA), explains the process for creating a Category I CPT code for payments and the difference with Category III temporary tracking codes.

Radiology dominates FDA-cleared AI, but reimbursement lags far behind

As of January 2026, there will only be two CPT category 1 payment codes for newer AI, despite there being hundreds of FDA-cleared medical imaging algorithms.

Court dismisses nurse practitioners’ lawsuit challenging definition of ‘doctor’

The court's ruling is backed by the American Medical Association, which submitted an amicus brief arguing that "scope creep" threatens patient safety.

heart data research doctor cardiologist AI

New-onset AFib is common after CABG—but typically not persistent or symptomatic

The study's authors questioned if these patients should even be given oral anticoagulation as currently recommended.

TAVR reinterventions: What new data tell us about redo, explant trends over time

TAVR reintervention rates remain low. However, they are slowly rising as the procedure is used more to treat patients with severe aortic stenosis. Researchers think this trend may continue going forward.

Real-world data link semaglutide, tirzepatide to improved heart failure outcomes

GLP-1 drugs have been taking the United States by storm in recent years. According to a new study of more than 90,000 patients, some of these medications can also make a big impact on reducing adverse heart failure outcomes.

Anders Gilberg, MGA, senior vice president, government affairs at Medical Group Management Association (MGMA), shares concerns about the draft fee schedule published in July. A major concern is the government possibly changing how relative value units (RVUs) are set, rather than allowing the American Medical Association and medical speciality representatives having a say. #MGMA

MGMA warns of government overreach in the proposed 2026 Medicare Physician Fee Schedule

The Medical Group Management Association shares concerns about the draft fee schedule published in July. A major concern is the government possibly changing how RVUs are set, rather than allowing the medical specialty representatives to have a say.